Article ; Online: What does cognitive screening reveal about early cognitive performance following endovascular clot retrieval and intravenous thrombolysis in acute ischaemic stroke?
2024 Volume 25
Abstract: Background Little is known regarding cognitive outcomes following treatment with endovascular clot retrieval (ECR) and intravenous tissue plasminogen activator (t-PA). We aimed to determine if there were any differences on a measure of cognitive ... ...
Abstract | Background Little is known regarding cognitive outcomes following treatment with endovascular clot retrieval (ECR) and intravenous tissue plasminogen activator (t-PA). We aimed to determine if there were any differences on a measure of cognitive screening between patients treated with ECR, t-PA, and those who were managed conservatively. Methods The medical records of ischaemic stroke patients admitted to Monash Medical Centre between January 2019 and December 2019 were retrospectively reviewed. Information extracted from medical records included age, sex, National Institutes of Health Stroke Scale at presentation, location of occlusion, treatment type, medical history, and cognitive screening performance measured by the Montreal Cognitive Assessment (MoCA). Results Eighty-two patients met the inclusion criteria (mean age = 66.5 ± 13.9; 49 male, 33 female). Patients treated with ECR performed significantly better on the MoCA (n = 36, 24.1 ± 4.3) compared to those who were managed conservatively (n = 26, 20.7 ± 5.5). Performance for patients treated with t-PA (n = 20, 23.9 ± 3.5) fell between the ECR and conservative management groups, but they did not significantly differ from either. Conclusion Our retrospective chart review found that ischaemic stroke patients treated with ECR appear to perform better on cognitive screening compared to patients who are managed conservatively. We also found that patients treated with ECR and t-PA appear to have similar cognitive screening performances in the acute stages following ischaemic stroke, although this finding is likely to have been impacted by group differences in stroke characteristics and may reflect the possibility that the ECR group performed better than expected based on their stroke severity. |
---|---|
MeSH term(s) | Humans ; Male ; Female ; Middle Aged ; Aged ; Aged, 80 and over ; Tissue Plasminogen Activator/therapeutic use ; Stroke/drug therapy ; Brain Ischemia/drug therapy ; Fibrinolytic Agents/therapeutic use ; Retrospective Studies ; Ischemic Stroke/drug therapy ; Thrombosis/drug therapy ; Thrombolytic Therapy/methods ; Cognition |
Chemical Substances | Tissue Plasminogen Activator (EC 3.4.21.68) ; Fibrinolytic Agents |
Language | English |
Publishing date | 2024-04-02 |
Publishing country | Australia |
Document type | Journal Article |
ZDB-ID | 2180113-7 |
ISSN | 1839-5252 ; 1443-9646 |
ISSN (online) | 1839-5252 |
ISSN | 1443-9646 |
DOI | 10.1071/IB23066 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.